Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

0.34p
   
  • Change Today:
      0.020p
  • 52 Week High: 0.39p
  • 52 Week Low: 0.12p
  • Currency: UK Pounds
  • Shares Issued: 6,783m
  • Volume: 30,223,132
  • Market Cap: £23.06m

Regulatory News

Raises £1.25 Million to Accelerate Programmes 16-Oct-2025 07:00 RNS
Half-year Report 30-Sep-2025 07:00 RNS
Solvonis secures exclusive CNS collaboration 28-Aug-2025 07:00 RNS
SVN-SDN-14 PTSD - Positive pre-clinical results 12-Aug-2025 07:00 RNS
Total Voting Rights 31-Jul-2025 16:30 RNS
Translational Bridging Studies 22-Jul-2025 07:00 RNS
Exercise of warrants 18-Jul-2025 11:03 RNS
£1m subscription to accelerate AI drug disc... 11-Jul-2025 07:00 RNS
Holding(s) in Company 08-Jul-2025 07:00 RNS
AGM Statement 27-Jun-2025 14:38 RNS
Holding(s) in Company 27-Jun-2025 08:54 RNS
Allowance of U.S. patent covering AI-supported CNS 23-Jun-2025 07:00 RNS
Initiation of AI supported CNS drug discovery 11-Jun-2025 07:30 RNS
Synthesis of development candidate for SVN-SDN-014 05-Jun-2025 07:00 RNS
Notice of Annual General Meeting 03-Jun-2025 16:30 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.34p
Change Today 0.020p
% Change 6.25 %
52 Week High 0.39p
52 Week Low 0.12p
Volume 30,223,132
Shares Issued 6,783m
Market Cap £23.06m

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average
2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average
Price Trend
35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average
40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 24-Oct-2025

Time Volume / Share Price
17:08 1,000,000 @ 0.34p
16:38 1,000,000 @ 0.34p
16:22 362,951 @ 0.33p
15:51 71,472 @ 0.34p
15:28 6,549 @ 0.34p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell
Finance Director Ryan Neats

Top of Page